Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-beta-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting

Stainton S. M.; Thabit A. K.; Kuti J. L.; Aslanzadeh J.; Nicolau D. P.

首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-beta-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting

【24h】

Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-beta-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting

机译：肠杆菌基乙酰胺膜易粘膜脂肪酸盐易受易受表型的新型哌啶/塔唑胺，易患泛β-内酰胺易感表型的患病率，患者特征和结果：对选择性报告的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases》 |2017年第8期|共2页
作者
Stainton S. M.; Thabit A. K.; Kuti J. L.; Aslanzadeh J.; Nicolau D. P.;
展开▼
作者单位

Ctr Antiinfect Res &

Dev Hartford CT 06102 USA;

Ctr Antiinfect Res &

Dev Hartford CT 06102 USA;

Ctr Antiinfect Res &

Dev Hartford CT 06102 USA;

Hartford Hosp Dept Microbiol Hartford CT 06115 USA;

Ctr Antiinfect Res &

Dev Hartford CT 06102 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
专利

1. Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-beta-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting [J] . Stainton S. M., Thabit A. K., Kuti J. L., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2017,第8期

机译：肠杆菌基乙酰胺膜易粘膜脂肪酸盐易受易受表型的新型哌啶/塔唑胺，易患泛β-内酰胺易感表型的患病率，患者特征和结果：对选择性报告的影响
2. Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study. [J] . Mohammedi I, Ploin D, Duperret S, Intensive care medicine . 2003,第7期

机译：ICU患者中对哌拉西林/他唑巴坦耐药的大肠杆菌的危险因素：一项临床研究。
3. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project [J] . Delgado-Valverde Mercedes, Torres Eva, Valiente-Mendez Adoracion, The Journal of Antimicrobial Chemotherapy . 2016,第2期

机译：哌拉西林/他唑巴坦的MIC对肠杆菌科菌血症菌血症患者预后的影响：细菌血症-MIC项目
4. Are Physicians Interested in the Quality of Life of their Patients? Usage of EHR-integrated Patient Reported Outcomes Data [C] . Fleur Fritz, Martin Dugas MEDINFO . 2013

机译：对他们患者生活质量感兴趣的医生是什么？ EHR-Integrated患者的用途报告了结果数据
5. Prevalence, characteristics and health consequences of abnormal body composition phenotypes in patients with malignant disease. [D] . Marques Maia do Prado, Carla. 2009

机译：恶性疾病患者身体组成异常表型的普遍性，特征和健康后果。
6. Population Pharmacokinetics of Piperacillin in Non-Critically Ill Patients with Bacteremia Caused by Enterobacteriaceae [O] . Vicente Merino-Bohórquez, Fernando Docobo-Pérez, Adoración Valiente-Méndez, 2021

机译：哌啶素的人口药代动力学在肠杆菌菌导致的菌血症患者中的非重症患者
7. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers [O] . Huang, Te-Din, Poirel, Laurent, Bogaerts, Pierre, 2017

机译：圆盘扩散对替莫西林和哌拉西林/他唑巴坦的耐药性，作为抗菌替代标记物，用于在OXA-48生产者盛行的地区检测生产碳青霉烯酶的肠杆菌科

Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-beta-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting

著录项

相似文献

相关主题

期刊订阅